Our results confirmed that the concentrations of sPD-1, sPD-L1, and sCTLA-4 are likely more associated with immune reactions probably in the lymphoid organs rather than in the tumour tissues of patients, as there were no differences in these levels before and after surgery except RCC patients. Here, HOXD13 is linked to renal cell carcinoma.